Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
– Sell
-16,225
Closed -$498K – 666
2024
Q4
$498K Sell
16,225
-2,338
-13% -$77.7K 0.03% 461
2024
Q3
$699K Buy
+18,563
New +$716K 0.05% 386
2021
Q4
– Sell
-9,090
Closed -$552K – 1029
2021
Q3
$552K Sell
9,090
-1,591
-15% -$93.3K 0.03% 813
2021
Q2
$641K Sell
10,681
-272
-2% -$13.6K 0.03% 778
2021
Q1
$517K Buy
10,953
+3,665
+50% +$151K 0.03% 874
2020
Q4
$274K Sell
7,288
-9,064
-55% -$299K 0.02% 1077
2020
Q3
$535K Buy
+16,352
New +$692K 0.02% 1083

Other funds holding ATEX

Winton Group's ATEX Position: Q1 2025 in Review

Winton Group sold out of Anterix (ATEX) in Q1 2025, closing a stake of 16,225 shares — an estimated $498K sold.

Winton Group first reported a position in ATEX in Q3 2020 and held it in 7 quarters. The position peaked at $699K in Q3 2024. 128 funds tracked by Wall St. Rank hold ATEX as of Q1 2025.

  • Winton Group reported no remaining Anterix position as of Q1 2025 after selling out during the quarter.
  • Winton Group sold 16,225 Anterix shares in Q1 2025, an estimated $498K.
  • Winton Group first reported a position in Anterix in Q3 2020 and held it in 7 quarters.
  • Winton Group's Anterix position peaked at $699K in Q3 2024.
  • 128 funds tracked by Wall St. Rank held Anterix as of Q1 2025.

Based on Winton Group's 13F filing for Q1 2025, filed 15 May 2025.